| Filed On | Filing |
|---|---|
| 22 Jun 2026 |
Form 4: Spencer John N Jr, Director
Granted 6,000 Stock Option |
| 22 Jun 2026 |
Form 4: Morgan Jayne, Director
Granted 6,000 Stock Option |
| 22 Jun 2026 |
Form 4: Mcnally Robert T, Director
Granted 6,000 Stock Option |
| 22 Jun 2026 |
Form 4: Lemerond Nicole, Director
Granted 6,000 Stock Option |
| 22 Jun 2026 |
Form 4: Kollintzas Dean G, Director
Granted 6,000 Stock Option |
| 22 Jun 2026 |
Form 4: Chase Randal D, Director
Granted 6,000 Stock Option |
| 22 Jun 2026 |
Form 4: Sharkey John W., VP, Business Development
Granted 17,600 Stock Option |
| 22 Jun 2026 |
Form 4: Reynolds Mark, CFO
Granted 17,600 Stock Option |
| 22 Jun 2026 |
Form 4: Newman Mark J, Chief Scientific Officer
Granted 17,600 Stock Option |
| 22 Jun 2026 |
Form 4: McKee Kelly T. Jr., Chief Medical Officer
Granted 17,600 Stock Option |
| 22 Jun 2026 |
Form 4: Dodd David A, Director
Granted 29,300 Stock Option |
| 20 Oct 2025 |
Form 4: Spencer John N Jr, Director
Bought 10,000 shares ($5.5K) |
| 08 Aug 2025 |
Form 4: McKee Kelly T. Jr., Chief Medical Officer
Bought 1,107 shares ($742) |
| 06 Jun 2025 |
Form 4: Lemerond Nicole, Director
Granted 10,000 Stock Option |
| 06 Jun 2025 |
Form 4: Chase Randal D, Director
Granted 10,000 Stock Option |
| 06 Jun 2025 |
Form 4: Kollintzas Dean G, Director
Granted 10,000 Stock Option |
| 06 Jun 2025 |
Form 4: Mcnally Robert T, Director
Granted 10,000 Stock Option |
| 06 Jun 2025 |
Form 4: Morgan Jayne, Director
Granted 10,000 Stock Option |
| 06 Jun 2025 |
Form 4: Spencer John N Jr, Director
Granted 10,000 Stock Option |
| 06 Jun 2025 |
Form 4: Newman Mark J, Chief Scientific Officer
Granted 70,000 Stock Option |
Loading...